Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D1U4BC
|
|||
| Drug Name |
BIIB-087
|
|||
| Synonyms |
rAAV2tYF-CB-hRS1
Click to Show/Hide
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | X-linked retinoschisis [ICD-11: 9B73.11] | Phase 1/2 | [1] | |
| Company |
Applied Genetic Technologies
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Retinoschisin (RS1) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02416622) Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.